Maintenance treatment with cetuximab versus observation in RAS wild-type metastatic colorectal cancer: Results of the randomized phase II PRODIGE 28-time UNICANCER study.

Valérie Boige,Eric Francois,Meher Ben Abdelghani,Jean-Marc Phelip,Valérie Le Brun-Ly,Laurent Mineur,Marie-Pierre Galais,Anne-Laure Villing,Vincent Hautefeuille,Laurent Miglianico,Christelle De La Fouchardiere,Dominique Genet,Nadia Levasseur,Charles-Briac Levaché,Nicolas Lachaux,Sophie Gourgou,Florence Castan,Olivier Bouché

Maintenance treatment with cetuximab versus observation in RAS wild-type metastatic colorectal cancer: Results of the randomized phase II PRODIGE 28-time UNICANCER study.

2021

Valérie Boige
Eric Francois
Meher Ben Abdelghani
Jean-Marc Phelip
Valérie Le Brun-Ly
Laurent Mineur
Marie-Pierre Galais
Anne-Laure Villing
Vincent Hautefeuille
Laurent Miglianico
Christelle De La Fouchardiere
Dominique Genet
Nadia Levasseur
Charles-Briac Levaché
Nicolas Lachaux
Sophie Gourgou
Florence Castan
Olivier Bouché

15Background: Compared to observation, maintenance therapy with a fluoropyrimidine +/- bevacizumab showed significant improvement in progression-free survival (PFS) but not in overall survival (OS)...

Keywords:

Colorectal cancer
Internal medicine
overall survival
Bevacizumab
Oncology
Cetuximab
Maintenance therapy
Medicine
Wild type

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations